Margarita Pons-Salort

Margarita Pons-Salort

Auto-generated profile, based on publicly available information

Margarita Pons-Salort

Imperial College London

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
PNPierre Nouvellet
Pierre Nouvellet
SBSangeeta Bhatia
Sangeeta Bhatia
ACAnne Cori
Anne Cori
KAKylie E. C. Ainslie
Kylie E. C. Ainslie
MBMarc Baguelin
Marc Baguelin
CDChristl A Donnelly
Christl A Donnelly
In response to the COVID-19 pandemic, countries have sought to control SARS-CoV-2 transmission by restricting population movement through social distancing interventions, thus reducing the number of contacts. Mobility data represent an important proxy measure of social distancing, and here, we characterise the relationship between transmission and mobility for 52 countries around the world. Transmission significantly decreased with the initial reduction in mobility in 73% of the countries analysed, but we found evidence of decoupling of transmission and mobility following the relaxation of strict control measures for 80% of countries. For the majority of countries, mobility explained a substantial proportion of the variation in transmissibility (median adjusted R-squared: 48%, interquartile range - IQR - across countries [27–77%]). Where a change in the relationship occurred, predictive ability decreased after the relaxation; from a median adjusted R-squared of 74% (IQR across countries [49–91%]) pre-relaxation, to a median adjusted R-squared of 30% (IQR across countries [12–48%]) post-relaxation. In countries with a clear relationship between mobility and transmission both before and after strict control measures were relaxed, mobility was associated with lower transmission rates after control measures were relaxed indicating that the beneficial effects of ongoing social distancing behaviours were substantial.

1 April 2018 in Journal of Clinical Virology
Verified
Journal Article
Open access
HHHeli Harvala
Heli Harvala
EBEeva Broberg
Eeva Broberg
KBKimberley Benschop
Kimberley Benschop
NBNatasa Berginc
Natasa Berginc
SLShamez Ladhani
Shamez Ladhani
TFThea Koelsen Fischer
Thea Koelsen Fischer
Enteroviruses (EV) can cause severe neurological and respiratory infections, and occasionally lead to devastating outbreaks as previously demonstrated with EV-A71 and EV-D68 in Europe. However, these infections are still often underdiagnosed and EV typing data is not currently collected at European level. In order to improve EV diagnostics, collate data on severe EV infections and monitor the circulation of EV types, we have established European non-polio enterovirus network (ENPEN). First task of this cross-border network has been to ensure prompt and adequate diagnosis of these infections in Europe, and hence we present recommendations for non-polio EV detection and typing based on the consensus view of this multidisciplinary team including experts from over 20 European countries. We recommend that respiratory and stool samples in addition to cerebrospinal fluid (CSF) and blood samples are submitted for EV testing from patients with suspected neurological infections. This is vital since viruses like EV-D68 are rarely detectable in CSF or stool samples. Furthermore, reverse transcriptase PCR (RT-PCR) targeting the 5'noncoding regions (5'NCR) should be used for diagnosis of EVs due to their sensitivity, specificity and short turnaround time. Sequencing of the VP1 capsid protein gene is recommended for EV typing; EV typing cannot be based on the 5'NCR sequences due to frequent recombination events and should not rely on virus isolation. Effective and standardized laboratory diagnostics and characterisation of circulating virus strains are the first step towards effective and continuous surveillance activities, which in turn will be used to provide better estimation on EV disease burden.

1 October 2015 in Current Opinion in Infectious Diseases
Verified
Journal Article
Open access
MPMargarita Pons-Salort
Margarita Pons-Salort
EPEdward P.K. Parker
Edward P.K. Parker
NGNicholas C. Grassly
Nicholas C. Grassly
Purpose of review There are over 100 serotypes of human enteroviruses, which cause a spectrum of illnesses, including meningitis, encephalitis, paralysis, myocarditis and rash. Increasing incidence of hand-foot-and-mouth disease in the Asia-Pacific region and recent outbreaks of enterovirus-associated disease, such as severe respiratory illness in the United States in 2014, highlight the threat of these viruses to human health. Recent findings We describe recent outbreaks of human enteroviruses and summarize knowledge gaps regarding their burden, spectrum of diseases and epidemiology. Summary Reported outbreaks of respiratory, neurological, skin and eye diseases associated with human enteroviruses have increased in frequency and size in recent years. Improved molecular diagnostics and genetic sequence analysis are beginning to reveal the complex dynamics of individual serotypes and genotypes, and their contribution to these outbreaks. However, the biological mechanisms underlying their emergence and transmission dynamics remain elusive. They are likely to involve changes in the virus, such as fitness, antigenicity, virulence or tropism, and in the human population, such as levels of sanitation and of homotypic and heterotypic immunity. Improvements in surveillance, serological surveys and detailed genetic and antigenic characterization of viral populations would help to elucidate these mechanisms. This will be important for the design of outbreak control and vaccine development strategies.

24 August 2018 in Science
Verified
Journal Article
Open access
PDF file
MPMargarita Pons-Salort
Margarita Pons-Salort
NGNicholas C. Grassly
Nicholas C. Grassly
Hidden truths of enteroviruses: Enteroviruses are important drivers of global health, but few countries undertake enterovirus surveillance. Pons-Salort and Grassly used Japanese surveillance data to model the interplay between the ratio of susceptible and immune individuals, accounting for declining birth and death rates, incomplete surveillance, and seasonality of infection (see the Perspective by Nikolay and Cauchemez). Enteroviruses have highly predictable yet highly nonlinear dynamics. The model also reveals signatures of increased pathogenicity and of antigenic change and transmissibility.Science, this issue p.800; see also p.755

5 March 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MPMargarita Pons-Salort
Margarita Pons-Salort
MOM. Steven Oberste
M. Steven Oberste
MPMark A. Pallansch
Mark A. Pallansch
GAGlen R. Abedi
Glen R. Abedi
STSaki Takahashi
Saki Takahashi
NGNicholas C. Grassly
Nicholas C. Grassly
Significance: Nonpolio enteroviruses are responsible for a high burden of neurological and other diseases and exhibit a peak in summer every year, but drivers of their seasonality are not clearly understood. We find that the seasonal pattern of enterovirus cases in the United States has a spatial structure comparable with that of prevaccination poliomyelitis. The average monthly distribution of cases is more flat in the south and has a more pronounced peak that occurs later toward the north, with the peak for poliomyelitis occurring approximately 1 month later than that for nonpolio enteroviruses. We find that climate, but not demography, is likely to explain this seasonality and identify the dew point temperature as a strong predictor of the intensity of enterovirus transmission.

10 March 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SPSang Woo Park
Sang Woo Park
MPMargarita Pons-Salort
Margarita Pons-Salort
KMKevin Messacar
Kevin Messacar
CCCamille Cook
Camille Cook
LMLindsay Meyers
Lindsay Meyers
BGBryan T. Grenfell
Bryan T. Grenfell
Mathematical modeling predicts an enterovirus D68, and therefore acute flaccid myelitis, outbreak in the absence of nonpharmaceutical interventions in 2020.